Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Company News

As of July 10, 2025 • 3:31 PM ET

Date/Time Source News Release
06/09/2025 07:00 AM EDT GlobeNewswire Sagimet Biosciences to Host Virtual KOL Event, "A New Mechanism of Action in Treating Acne: Update on Positive Phase 3 Denifanstat Trial for the Treatment of Moderate to Severe Acne" on June 16, 2025
06/04/2025 05:00 AM EDT GlobeNewswire Sagimet Biosciences Announces Positive Phase 3 Results for Denifanstat for the Treatment of Moderate-to-Severe Acne from Partner Ascletis
05/22/2025 08:00 AM EDT GlobeNewswire Sagimet Biosciences to Host Virtual KOL Event, "Evaluating the Synergistic Potential of a Combination of Denifanstat and Resmetirom for the Treatment of Metabolic Dysfunction-Associated Steatohepatitis (MASH)" on May 29, 2025
05/08/2025 06:00 AM EDT GlobeNewswire Sagimet Biosciences Reports First Quarter 2025 Financial Results and Provides Corporate Updates
04/23/2025 08:00 AM EDT GlobeNewswire Sagimet Biosciences Announces Upcoming Presentations at EASL Congress 2025
03/12/2025 07:30 AM EDT GlobeNewswire Sagimet Biosciences Reports Full Year 2024 Financial Results and Provides Corporate Updates
03/11/2025 08:00 AM EDT GlobeNewswire Sagimet Biosciences Announces Clearance of IND for FASN Inhibitor TVB-3567, to be Developed for the Treatment of Acne
02/19/2025 08:00 AM EST GlobeNewswire Sagimet Biosciences Announces Oral Presentation at the MASH Pathogenesis and Therapeutic Approaches Keystone Symposium
01/06/2025 08:00 AM EST GlobeNewswire Sagimet Biosciences Announces Oral Presentation at the 9th Annual MASH-TAG 2025 Conference
11/26/2024 08:00 AM EST GlobeNewswire Sagimet Biosciences to Participate in the Piper Sandler 36th Annual Healthcare Conference
Page

Additional News

As of July 10, 2025 • 3:31 PM ET

Date/Time Source News Release
06/17/2025 09:14 PM EDT SeekingAlpha Tracking Baker Brothers Portfolio - Q1 2025 Update
06/11/2025 12:00 PM EDT Zacks What Makes Sagimet Biosciences Inc. (SGMT) a Strong Momentum Stock: Buy Now?
06/09/2025 09:55 AM EDT Zacks Wall Street Analysts Predict a 437.05% Upside in Sagimet Biosciences Inc. (SGMT): Here's What You Should Know
06/04/2025 01:45 PM EDT SeekingAlpha Sagimet: Positive China Partner Acne Vulgaris Data Bodes Well For TVB-3567
06/04/2025 06:54 AM EDT SeekingAlpha Sagimet climbs as acne therapy hits main goals in late-stage trial in China
05/21/2025 07:00 AM EDT US Earnings Reports Expected US Company Earnings on Wednesday, May 21st, 2025
05/21/2025 05:31 AM EDT US Earnings Reports Expected earnings - Sagimet Biosciences Inc.
05/08/2025 12:24 PM EDT SeekingAlpha Sagimet Biosciences reports Q1 results
03/13/2025 05:31 AM EDT US Earnings Reports Expected earnings - Sagimet Biosciences Inc.
03/12/2025 07:55 AM EDT SeekingAlpha Sagimet Biosciences GAAP EPS of -$0.50 beats by $0.13
Page

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.